ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 17.1096 ↓ -0.32%
[as on 26 December, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option -8.55% -0.32% -0.27% -2.64% 0.45% -6.16% 21.12%---

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.31% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.69%

Equity

NameSymbol / ISINSectorWeight %QuantityQty change %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.96%150888-
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.97%31001-
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services6.35%19262+8.37%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.71%115755-
Torrent Pharmaceuticals LimitedTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology4.51%29519+2.28%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology4.43%137055+5.20%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services3.98%90524-6.06%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology3.70%75614-
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services3.62%124462-
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology3.07%47677+43.27%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology3.04%36050-
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.95%12453-
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology2.82%3979-
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology2.57%49979+10.37%
Wockhardt LimitedWOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology2.27%41176-
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.20%1769+4.67%
Healthcare Global Enterprises LimitedHCG (INE075I01017)Healthcare Services1.77%55261-12.30%
Glenmark Pharmaceuticals LimitedGLENMARK (INE935A01035)Pharmaceuticals & Biotechnology1.73%21296+57.06%
Laurus Labs LimitedLAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology1.69%41369+17.32%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.53%38836-14.60%
FDC LimitedFDC (INE258B01022)Pharmaceuticals & Biotechnology1.40%70933-
Sumitomo Chemical India LimitedSUMICHEM (INE258G01013)Fertilizers & Agrochemicals1.35%62461+3.78%
SBI Life Insurance Company LimitedSBILIFE (INE123W01016)Insurance1.25%14830-
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.23%22488-
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology1.22%11962-56.06%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology1.21%75706+70.96%
Onesource Specialty Pharma LimitedONESOURCE (INE013P01021)Pharmaceuticals & Biotechnology1.19%14989+19.65%
Rainbow Childrens Medicare LimitedRAINBOW (INE961O01016)Healthcare Services1.19%20150-
Orchid Pharma LimitedORCHPHARMA (INE191A01027)Pharmaceuticals & Biotechnology1.13%36258-
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology1.13%131285+118.43%
Standard Glass Lining Technology LtdSGLTL (INE0M4D01010)Industrial Manufacturing1.05%133598-
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology0.99%8765+10.87%
Poly Medicure LimitedPOLYMED (INE205C01021)Healthcare Equipment & Supplies0.93%10779-
Caplin Point Laboratories LimitedCAPLIPOINT (INE475E01026)Pharmaceuticals & Biotechnology0.86%9867-
Supriya Lifescience LimitedSUPRIYA (INE07RO01027)Pharmaceuticals & Biotechnology0.85%25370-23.87%
Linde India LimitedLINDEINDIA (INE473A01011)Chemicals & Petrochemicals0.81%3135-
Shilpa Medicare LimitedSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology0.75%49568-
UPL LimitedUPL (INE628A01036)Fertilizers & Agrochemicals0.72%23209-
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology0.70%16792+16.22%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.48%17159-

Debt

NameRatingWeight %
Portfolio data is as on date 31 October, 2025

NAV (Net asset value) history

ITI Pharma and Healthcare Fund - Direct Plan - Growth Option - 30 days NAV history

DateNAV
26 December, 202517.1096
24 December, 202517.1650
23 December, 202517.2084
22 December, 202517.2622
19 December, 202517.1563
18 December, 202516.9670
17 December, 202516.9934
16 December, 202517.1180
15 December, 202517.2020
12 December, 202517.2581
11 December, 202517.2167
10 December, 202517.1065
9 December, 202517.1050
8 December, 202517.1126
5 December, 202517.4077
4 December, 202517.4135
3 December, 202517.3897
2 December, 202517.4542
1 December, 202517.4898
28 November, 202517.5718
27 November, 202517.5408
26 November, 202517.5731
25 November, 202517.4076
24 November, 202517.3503
21 November, 202517.4406
20 November, 202517.5419
19 November, 202517.5702
18 November, 202517.5512
17 November, 202517.6951
14 November, 202517.6249

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The latest NAV of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is 17.1096 as on 26 December, 2025.
  • What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are -8.55% as on 26 December, 2025.
  • What are 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are -6.16% as on 26 December, 2025.
  • What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 21.12% as on 26 December, 2025.